AVALO THERAPEUTICS, INC. Increase (Decrease) in Income Taxes Payable
AVALO THERAPEUTICS, INC. (AVTX) reported Increase (Decrease) in Income Taxes Payable of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2023-03-29
- AVALO THERAPEUTICS, INC. increase (decrease) in income taxes payable for the quarter ending 2021-12-31 was $0.00.
- AVALO THERAPEUTICS, INC. increase (decrease) in income taxes payable for the quarter ending 2021-09-30 was $0.00.
- AVALO THERAPEUTICS, INC. increase (decrease) in income taxes payable for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- AVALO THERAPEUTICS, INC. increase (decrease) in income taxes payable for the quarter ending 2021-03-31 was $0.00.
- AVALO THERAPEUTICS, INC. increase (decrease) in income taxes payable for fiscal 2022 was $0.00.
- AVALO THERAPEUTICS, INC. increase (decrease) in income taxes payable for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- AVALO THERAPEUTICS, INC. increase (decrease) in income taxes payable for fiscal 2020 was $288.00K.
- AVALO THERAPEUTICS, INC. increase (decrease) in income taxes payable for fiscal 2019 was -$1.48M.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 3 month as first filed | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 6 month as first filed | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 9 month as first filed | Increase (Decrease) in Income Taxes Payable 12 month | Increase (Decrease) in Income Taxes Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-29 | |||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $0.00 derived: sum of 2 quarters · filed 2023-03-29 | $0.00 derived: sum of 3 quarters · filed 2023-03-29 | $0.00 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2022-03-02 | ||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $0.00 10-Q · filed 2021-08-02 | $0.00 derived: sum of 3 quarters · filed 2022-03-02 | $0.00 derived: sum of 4 quarters · filed 2022-03-02 | ||||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-03-02 | $0.00 derived: sum of 3 quarters · filed 2022-03-02 | $839.00K derived: sum of 4 quarters · filed 2022-03-02 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $0.00 derived: sum of 2 quarters · filed 2022-03-02 | $839.00K derived: sum of 3 quarters · filed 2022-03-02 | $288.00K 10-K · filed 2022-03-02 | $288.33K 10-K · filed 2021-03-08 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $839.00K derived: sum of 2 quarters · filed 2021-11-09 | $288.00K 10-Q · filed 2021-11-09 | $288.33K 10-Q · filed 2020-11-09 | -$174.78K derived: sum of 4 quarters · filed 2021-11-09 | |||
| 2020-06-30 | $839.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $288.00K 10-Q · filed 2021-08-02 | $288.33K 10-Q · filed 2020-08-06 | -$174.78K derived: sum of 3 quarters · filed 2021-08-02 | -$552.80K derived: sum of 4 quarters · filed 2021-08-02 | |||
| 2020-03-31 | -$551.00K 10-Q · filed 2021-05-13 | -$551.67K 10-Q · filed 2020-05-07 | -$1.01M derived: sum of 2 quarters · filed 2021-05-13 | -$1.39M derived: sum of 3 quarters · filed 2021-05-13 | -$1.81M derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | -$462.78K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | -$840.80K derived: sum of 2 quarters · filed 2021-03-08 | -$1.26M derived: sum of 3 quarters · filed 2021-03-08 | -$1.48M 10-K · filed 2021-03-08 | ||||
| 2019-09-30 | -$378.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$800.20K derived: sum of 2 quarters · filed 2020-11-09 | -$1.02M 10-Q · filed 2020-11-09 | -$1.18M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | -$422.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$639.78K 10-Q · filed 2020-08-06 | -$802.57K derived: sum of 3 quarters · filed 2020-08-06 | -$778.57K derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$217.61K 10-Q · filed 2020-05-07 | -$380.40K derived: sum of 2 quarters · filed 2020-05-07 | -$356.40K derived: sum of 3 quarters · filed 2020-05-07 | -$451.90K derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$162.79K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | -$138.79K derived: sum of 2 quarters · filed 2020-03-11 | -$234.29K derived: sum of 3 quarters · filed 2020-03-11 | -$226.89K 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$71.50K derived: sum of 2 quarters · filed 2019-11-14 | -$64.10K 10-Q · filed 2019-11-14 | -$1.03M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | -$95.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$88.10K 10-Q · filed 2019-08-08 | -$1.06M derived: sum of 3 quarters · filed 2019-08-08 | $2.17M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $7.40K 10-Q · filed 2019-05-09 | -$963.45K derived: sum of 2 quarters · filed 2019-05-09 | $2.27M derived: sum of 3 quarters · filed 2019-05-09 | $2.27M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | -$970.85K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $2.26M derived: sum of 2 quarters · filed 2019-03-18 | $2.26M derived: sum of 3 quarters · filed 2019-03-18 | $2.26M 10-K · filed 2019-03-18 | ||||
| 2017-09-30 | $3.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $3.23M derived: sum of 2 quarters · filed 2018-11-13 | $3.23M 10-Q · filed 2018-11-13 | $3.23M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | $0.00 derived: sum of 3 quarters · filed 2018-08-09 | |||||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-11 | $0.00 derived: sum of 2 quarters · filed 2018-05-11 | ||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 10-K · filed 2018-04-02 | ||||||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-07 | |||||||
| 2015-12-31 | $0.00 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |